AURORA CANNABIS INC 
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 272M 198M 15.61B | Sales 2025 * | 320M 233M 18.35B | Capitalization | 429M 312M 24.64B |
|---|---|---|---|---|---|
| Net income 2024 * | -61M -44.38M -3.5B | Net income 2025 * | -7M -5.09M -402M | EV / Sales 2024 * | 1.58 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.34 x |
| P/E ratio 2024 * |
-5.03
x | P/E ratio 2025 * |
-48.4
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
Latest transcript on Aurora Cannabis Inc
More recommendations
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 52 | 05/07/20 |
Simona King
DFI | Director of Finance/CFO | 52 | 02-20 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ronald Funk
CHM | Chairman | 67 | 24/07/18 |
Michael Singer
BRD | Director/Board Member | 60 | 19/05/16 |
Adam Szweras
BRD | Director/Board Member | 52 | 09/08/15 |
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Companyâs segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
Sector
Pharmaceuticals
Calendar
19/06/2024
- Q4 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +32.48% | 5.8B | |
| -26.22% | 3.92B | |
| +4.73% | 3.28B | |
| -20.86% | 2.77B | |
| -11.88% | 2.26B | |
| +46.64% | 1.95B | |
| -16.71% | 1.52B | |
| +44.65% | 1.49B | |
| -9.60% | 1.49B |
